$216M Settlement For Arkansas In Opioid MDL

$216M Settlement For Arkansas In Opioid MDL

Introduction

Attorney General Leslie Rutledge of Arkansas announced a deal with opioid manufacturers and distributors that requires the drugmakers to pay $216 million to Arkansas in the opioid MDL.

Three major pharmaceutical distributors, Cardinal, McKesson, and AmerisourceBergen, along with opioid manufacturer Johnson & Johnson (J&J), will pay the settlement amount to Arkansas. The agreement will settle a number of opioid litigations faced by the companies and will also prevent the future opioid crisis.

The Attorney General said that opioid overdose has resulted in several deaths in Arkansas during the past decade. Many families from the state have lost their loved ones because of the opioid crisis. The settlement will not bring back the lost lives, but it will surely help to prevent opioid addiction problems among the people of Arkansas. The settlement amount will be used to educate and treat people suffering from opioid addiction problems.

Nearly 4000 opioid lawsuits have been filed in federal and state courts across the country, and the agreement would resolve those claims. States can sign the agreement in 30 days, whereas the local governments have up to 150 days to participate in the deal.

Arkansas will sign the agreement after reviewing the final documents of the deal. The state would receive $216 million as a settlement for the opioid crisis.

The settlement is a part of the $26 billion deal announced by a federal judge to tackle the opioid epidemic throughout the nation. J&J will pay $5 billion, and the distributors will pay the remaining amount of $21 billion.